Tag: Markham

May 21, 2019

Canntab Receives Cultivation Licence for Industrial Hemp

Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading innovator in hard pill oral dose therapeutic cannabinoid...
January 29, 2019

The Flowr Corporation CEO: High Yield is the Key to Profitability in the Cannabis Industry

The Flowr Corporation CEO Vinay Tolia provides an overview of the opportunities and challenges for the newly legalized Canadian cannabis...
November 14, 2018

Canntab Announces Correction to Press Release

Canntab Therapeutics (CSE:PILL) (“Canntab” or the “Company”) wishes to issue a correction to its press release disseminated earlier today, which...
November 14, 2018

Canntab Corporate Update

Canntab Therapeutics (CSE:PILL) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid...
October 25, 2018

Flowr CEO Vinay Tolia Appointed to Board of Directors

Flowr Also Announces Appointment of Independent Trading Group, Inc.
October 18, 2018

Canntab Files Application to Become Licensed Producer

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company") a leader in the development of precision oral dose cannabis tablets and capsules,...
September 5, 2018

Vinay Tolia To Become CEO Of The Flowr Corporation

The Flowr Corporation (“Flowr” or “Company”), a vertically integrated cannabis company and Health Canada Licensed Producer, announced today that it...